. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Mol Genet Metab. 2013 Jul 19;110(3):10.1016/j.ymgme.2013.07.010. doi: 10.1016/j.ymgme.2013.07.010

Table 2.

Phe (μmol/L) at baseline, average Phe during screening, and average Phe during BH4 treatment period.

Follow-up BH4 Responder Sample (n = 12)

	Baseline	Screening	Follow-up
Phe mean (SD)^, ^*	653 (322)	317 (237)	409 (256)
Phe range	200 - 1108	51 - 881	136 - 897

Note:

significant difference between baseline and screening, p < .001;

^**

significant difference between baseline and follow-up, p < .005.